Literature DB >> 2916450

Fibronectin turnover in the premature neonate measured with [15N]glycine.

R A Polin1, M C Yoder, S D Douglas, W McNelis, I Nissim, M Yudkoff.   

Abstract

Fibronectin is a large-molecular-weight glycoprotein present on most cell surfaces and in plasma. Plasma fibronectin concentrations in neonates are lower than those in adults and a direct relationship exists between plasma concentration and gestational age. We determined the half-life and fractional synthetic rate (FSR) of plasma fibronectin in the premature infant. Infants and adults received a loading dose of [15N]glycine followed by a constant infusion [15N]glycine incorporation into plasma fibronectin and urine hippurate was determined by gas chromatography-mass spectrometry. The plasma fibronectin FSR in the preterm neonates was 15.5 +/- 9.9%/d(means +/- SD) and the half-life was 5.55 +/- 2.25 d. Birth weight correlated inversely with plasma fibronectin half-life. In the adults the plasma fibronectin FSR ranged from 20 to 87%/d and half-life ranged between 0.79 and 3.47 d. These data suggest that decreased plasma fibronectin levels in preterm infants are due to reduced FSRs rather than to greater turnover of a relatively small plasma pool.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2916450     DOI: 10.1093/ajcn/49.2.314

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  2 in total

1.  The laminin alpha-1 chain derived peptide, AG73, increases fibronectin levels in breast and melanoma cancer cells.

Authors:  Jean A Engbring; Rydhwana Hossain; Sherilyn J VanOsdol; Benjamin Kaplan-Singer; Michael Wu; Suguru Hibino; Jennifer E Koblinski
Journal:  Clin Exp Metastasis       Date:  2008-01-10       Impact factor: 5.150

2.  Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation.

Authors:  C Thompson; F A Blumenstock; T M Saba; P J Feustel; J E Kaplan; J B Fortune; L Hough; V Gray
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.